Stuart A. Arbuckle - 02 May 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
02 May 2022
Net transactions value
-$80,778
Form type
4
Filing time
04 May 2022, 17:21:12 UTC
Previous filing
28 Feb 2022
Next filing
18 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale $80,778 -306 -0.47% $263.98 64,760 02 May 2022 Direct F1
holding VRTX Common Stock 140 02 May 2022 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.